San Diego, CA (PRWEB) April 19, 2011
Ivera Medical Corporation, the manufacturer of Curos Port Protectors, a simple, disposable infection prevention product that guards against central-line associated bloodstream infections (CLABSI), has introduced a new means of bringing Curos protection to the point of care making needleless connector disinfection compliance and cost containment easier than ever.
The new Curos Strip provides caregivers with a perfectly accessible dispenser for Curos port protectors anywhere the disinfection caps are needed. The ten-cap, foil-backed dispenser can be hung on an IV pole or other convenient bedside location so that nurses have easy access to consistent and reliable passive disinfection during every IV access. The availability of in-room Curos Port Protectors is especially important for safe needleless connector disinfection in isolation rooms and other areas where cross-contamination is a concern.
Ivera CEO, Bob Rogers said, “Nurses walk roughly 3 miles in a 10 hour shift gathering supplies, medications and other tools they need to care for patients. Time previously spent running around can be dedicated to patient-care activities. With Curos Strips we have an additional way to help nurses cut down steps while reducing hospital acquired bloodstream infections.”
With two dispenser options—the Curos Strip or individual Curos—nurses can conveniently comply with valve disinfection protocols and reduce hospital acquired infections by simply peeling the foil seal off the distinctive green cap and twisting Curos over the top of any luer-activated needleless valve or IV access port. Inside Curos a 70% IPA (isopropyl alcohol) saturated sponge-like foam automatically provides effective, consistent and reliable passive disinfection of the valve.
A recent study conducted by a 376-bed academic medical center found Curos more effective than a typical alcohol swab procedure in reducing CLABSI and contaminated blood cultures drawn via central venous catheters, in part, because disinfection compliance with Curos can be easily monitored and therefore is high (greater than 85 percent on average). Researchers saw an 86.2 percent reduction in CLABSI and a 92 percent fall in contaminated blood cultures equating to an estimated annualized cost avoidance of $500,000.
“We know that Curos is having a significant impact on bloodstream infections,” said Christine Arme, Western Vice president of Sales for Ivera. “The new Curos Strip dispenser stems from the input of grateful and innovative nurses who appreciate a product that efficiently supports them in protecting their patients.”
For more information go to http://www.iveramed.com/curos-port-protector/curos-strip, contact Ivera Medical at email@example.com or call 888-861-8228.
About Ivera Medical
Ivera Medical Corporation is focused on the design, development, manufacture, marketing and sale of innovative products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA’s 510(k) market clearance. For more information about Curos and Ivera Medical, visit the
# # #